Raymond James & Associates’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.06M | Buy |
46,547
+23,326
| +100% | +$1.03M | ﹤0.01% | 2200 |
|
|
2024
Q2 | $840K | Sell |
23,221
-9,277
| -29% | -$336K | ﹤0.01% | 2728 |
|
|
2024
Q1 | $1.4M | Buy |
32,498
+5,299
| +19% | +$228K | ﹤0.01% | 2378 |
|
|
2023
Q4 | $418K | Sell |
27,199
-1,346
| -5% | -$20.7K | ﹤0.01% | 3041 |
|
|
2023
Q3 | $391K | Sell |
28,545
-3,500
| -11% | -$48K | ﹤0.01% | 3019 |
|
|
2023
Q2 | $514K | Buy |
32,045
+6,760
| +27% | +$108K | ﹤0.01% | 2905 |
|
|
2023
Q1 | $196K | Buy |
+25,285
| New | +$196K | ﹤0.01% | 3467 |
|